Wockhardt, on 17 September 2006, signed an MoU with Maharashtra Industrial Development Corporation to set up a special economic zone at Shendra in Aurangabad district of Maharashtra. The company will  invest Rs.700 crore over three-four years for the proposed SEZ .

The facility to spread over 107 ha of land leased by MIDC at Shendra will include state-of-the-art pharmaceutical and biopharmaceutical manufacturing and research facility.

The SEZ will house manufacturing facilities for active pharmaceutical ingredients, biopharmaceuticals, R&D centre, effluent treatment plant, a corporate office, warehouse and a residential and recreational complex. It is  expected to provide employment to about 2,000 people.

At present, Wockhardt has 10 manufacturing facilities, including one in the UK, most of which are certified by international regulatory bodies such as the USFDA. The proposed plants at the SEZ will also be built for international regulatory compliance.

Related Links:
Project profile

← All latest storiesBack to top →